Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of ca...
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors
Biggest stock movers Thursday: NVDA, OKTA, MRNA, and more
Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
U.S. stock market midday update: Twist up 9.53%: AI pharmaceutical leader in demand, funds pouring in to boost stock price
U.S. stock market midday update: GRML down 12.78% on increased volume, no negative news but funds are fleeing?
The disjointed reality of 2026: AI booms, gold rushes, and bankruptcy